SyntekaBio

226330 · KOSDAQ · Information Technology · SMALL CAP

Updated contract terms.

SyntekaBio updated a previously disclosed supply contract with Rudacure Co., Ltd., now worth US$268K, about 324.13% of its recent annual revenue, running through Jun 2026.

Supply contract([Amended] Supply contract signed)· FILED 2026-05-28· RCEPT 20260528901032

US$268KContract value
324.13%vs. recent revenue
Jun 2026Throughfrom Dec 2024

Converted at 1 USD ≈ ₩1,495.29 (filing-date rate, 2026-05-28 close)

What happened

SyntekaBio updated a previously disclosed supply contract with Rudacure Co., Ltd., now worth US$268K, about 324.13% of its recent annual revenue, running through Jun 2026.

For context, this single contract equals about 324.13% of the company's most recent annual revenue.

CounterpartyRudacure Co., Ltd.
Contract valueUS$268K
vs. recent revenue324.13%
ThroughJun 2026 (from Dec 2024)
Filed2026-05-28, [Amended] Supply contract signed
SourceDART rcept 20260528901032 → open original filing

Source: DART. Information only, not investment advice.

For informational purposes only. This is not investment advice, a recommendation, or a solicitation to buy or sell any security. Do your own research; any investment decision is your own responsibility.

Data from DART, Korea's official corporate-filing system. Data sourced from official DART filings. Accuracy is not guaranteed. Figures are as of the date shown. As of 2026-05-28 (KST). · Converted at 1 USD ≈ ₩1,325 (rate of 2026-10-21).

Company summaries are generated and may contain errors; financial figures are mapped directly from official filings.